American College of Cardiology and Medscape

• Recurrent Atypical Chest Pain in a 62-Year-Old Woman A 62-year-old woman presents with atypical chest pain and mild shortness of breath manifesting with recurring, fleeting, dull, nonradiating pain, seemingly caused by high-stress environments. What's going on?
  American College of Cardiology & Medscape , May 09, 2022
• Hands-on for HF: New Considerations for Cardiac Rehab   Drs Daniel Forman and Gordon Reeves discuss how the REHAB-HF trial results inform potential new directions in exercise training for both HFpEF and HFrEF patients that may be beneficial.
  American College of Cardiology & Medscape , May 05, 2022
• HFpEF: New Treatments Provide 'Hope'   Drs Clyde Yancy and Ravi Patel discuss contemporary treatment approaches for heart failure with preserved ejection fraction.
  American College of Cardiology & Medscape , March 28, 2022
• Is Diabetes a Cardiovascular Risk Equivalent?   Drs Jay Shubrook and Mark Villalon discuss cardiovascular risk stratification and management in patients with diabetes.
  American College of Cardiology & Medscape , March 15, 2022
• Heart Failure Imaging: Where Are We Now? Experts discuss the current role of imaging modalities, particularly TTE and CMR, in monitoring and diagnosing cardiovascular diseases that can lead to heart failure.
  American College of Cardiology & Medscape , January 07, 2022
• Does Vitamin D Have a Role in Cancer, CVD, and COVID?   Drs Pam Taub, JoAnn Manson, and Michael Holick discuss vitamin D and the importance of maintaining sufficient levels for overall health.
  American College of Cardiology & Medscape , December 01, 2021
• PPCM Management: 5 Things to Know Dr Mattina highlights key aspects to diagnosing and treating peripartum cardiomyopathy.
  American College of Cardiology & Medscape , November 02, 2021
• Optimal Use of SGLT2 Inhibitors and GLP-1 Agonists In light of the vast benefits demonstrated by SGLT2 inhibitors and GLP-1 agonists, Dr Matthew Budoff highlights how cardiologists and preventive care physicians can optimize their use in patient care.
  American College of Cardiology & Medscape , October 18, 2021
• Hypertrophic Cardiomyopathy Risk Stratification Current and novel markers show promise for better accuracy of risk assessment for sudden cardiac death in patients with this condition.
  American College of Cardiology & Medscape , October 05, 2021
• Improving Cardiometabolic Health in the COVID-19 Era   Dr Jay Shubrook discusses five tips for improving cardiometabolic health in relation to COVID-19.
  American College of Cardiology & Medscape , August 25, 2021
• Cancer Therapy and Myocardial Dysfunction: 5 Things to Know An expert overview of some key aspects to preventing, monitoring, and managing cardiac dysfunction related to cancer therapy.
  American College of Cardiology & Medscape , July 26, 2021
• 2018 AHA/ACC Multisociety Cholesterol Guideline vs 2019 ESC/EAS Dyslipidemia Guidelines The updated AHA/ACC guideline refined the secondary prevention category and expanded primary prevention to all age groups. Here are five notable comparisons between the AHA/ACC and ESC/EAS guidelines.
  American College of Cardiology & Medscape , June 30, 2021
• Cardiologists Should Be More Involved in Treating NAFLD/NASH   Drs Seth Baum and Jay Shubrook on why the vast-reach impacts of fatty liver disease require an 'all-hands-on-deck' approach.
  American College of Cardiology & Medscape , May 24, 2021
• Navigating Prior Authorization and Costs for HFrEF Drugs Online tools and decision aids can help clinicians and patients work through the barriers that have slowed the use of new drugs such as sacubitril-valsartan.
  American College of Cardiology & Medscape , May 11, 2021
• An Expert's Guide to Managing Familial Hypercholesterolemia   Dr Seth Baum on how to recognize both homozygous and heterozygous FM, and treat them before they inflict their tremendous damage.
  American College of Cardiology & Medscape , April 21, 2021
• GLP-1 Agonists and SGLT2 Inhibitors in HF Treatment Although study results have been postive, particularly for SGLT2 inhibitors, questions still need to be answered about how these agents fit into treatment for heart failure.
  American College of Cardiology & Medscape , April 14, 2021
• Antiplatelet Therapy: Where Do We Stand Now?   Can duration of DAPT be shortened? Is single antiplatelet therapy an option? Drs Bangalore and Baber discuss these topics in antiplatelet therapy and more.
  American College of Cardiology & Medscape , January 27, 2021
• Does the Ketogenic Diet Benefit Patients With Heart Failure? An expert review of the latest studies on ketogenic diets sheds light on contrasting results.
  American College of Cardiology & Medscape , January 13, 2021
• CAC Scores, Lp(a), CRP: CV Screening in Real Life   Lipidologists Budoff and Baum discuss real-life implications of the CAC score and how to apply it, and other measures, to everyday patients.
  American College of Cardiology & Medscape , November 23, 2020
• Remote Monitoring Systems in Heart Failure The latest implantable devices may help in preventing rehospitalization in patients with heart failure.
  American College of Cardiology & Medscape , November 10, 2020